Evolutionary Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 186.67K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 120.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 186.67K shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | |
| 2014-12-31 | 120.00K shares 10-K · filed 2016-02-19 |